Medtronic PLC (NYSE:MDT)

Delayed Data
As of 4:01pm ET
 -0.69 / -0.79%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Medtronic Plc is engaged in the medical technology-alleviating pain, restoring health, and extending life for millions of people around the world. Its customers include hospitals, clinics, third-party health care providers, distributors, and other institutions, including governmental health care programs and group purchasing organizations. The company operates through four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group consist of three divisions : Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascular. The Minimally Invasive Technologies Group consists of two divisions: Surgical Solutions and Patient Monitoring and Recovery. The Restorative Therapies Group consists of four divisions: Spine, Neuromodulation, Surgical Technologies and Neurovascular. The Diabetes Group consists of three divisions: Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The company was founded on January 26, 2015 and is headquartered in Dublin, Ireland.

Contact Information

Medtronic Plc
20 On Hatch
Dublin Dublin 2
P:(531) 438-1700
Investor Relations:
(763) 505-2692



Mutual fund holders48.85%
Other institutional35.24%
Individual stakeholders0.15%

Top Executives

Omar S. IshrakChairman & Chief Executive Officer
Mark PloofSenior Vice President-Global Operations
Karen L. ParkhillChief Financial Officer & Executive Vice President
Geoffrey Straub MarthaExecutive VP & President-Restorative Therapies
Carol A. SurfaceChief Human Resources Officer & Senior VP